Necrosis, a well-orchestrated form of cell demise: Signalling cascades, important mediators and concomitant immune response

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1757, Issue 9-10, 2006, Pages 1371-1387

  Festjens, Nele ^a   Vanden Berghe, Tom ^a   Vandenabeele, Peter ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Calcium; Inflammation; Mitochondria; Phospholipases; Proteases; ROS

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CALCIUM; CALMODULIN; CALPAIN; CERAMIDE; CYTOKINE; DEATH RECEPTOR; FAS LIGAND; FLICE INHIBITORY PROTEIN; NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; PROTEINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TUMOR NECROSIS FACTOR;

APOPTOSIS; AUTOIMMUNE DISEASE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CANCER CELL CULTURE; CD4+ T LYMPHOCYTE; CELL DAMAGE; CELL DEATH; CELL STIMULATION; CITRIC ACID CYCLE; CYTOKINE PRODUCTION; CYTOTOXICITY; EMBRYO CELL; EXCITOTOXICITY; EXTRACELLULAR SPACE; FIBROSARCOMA; GENE OVEREXPRESSION; GLYCOLYSIS; IMMUNOREGULATION; LEUKEMIA CELL LINE; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL DEATH; CYTOSKELETON; HUMANS; INFLAMMATION MEDIATORS; NECROSIS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 33749178260     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2006.06.014     Document Type: Review

References (239)

1. Clarke P.G. Apoptosis: from morphological types of cell death to interacting pathways. Trends Pharmacol. Sci. 23 (2002) 308-309 (author reply 310)
2. Schweichel J.U., and Merker H.J. The morphology of various types of cell death in prenatal tissues. Teratology 7 (1973) 253-266
3. Ellis R.E., Yuan J.Y., and Horvitz H.R. Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7 (1991) 663-698
4. Lamkanfi M., Declercq W., Kalai M., Saelens X., and Vandenabeele P. Alice in caspase land, A phylogenetic analysis of caspases from worm to man. Cell Death Differ. 9 (2002) 358-361
5. Beyaert R., Van Loo G., Heyninck K., and Vandenabeele P. Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas. Int. Rev. Cytol. 214 (2002) 225-272
6. Festjens N., van Gurp M., van Loo G., Saelens X., and Vandenabeele P. Bcl-2 family members as sentinels of cellular integrity and role of mitochondrial intermembrane space proteins in apoptotic cell death. Acta Haematol. 111 (2004) 7-27
7. Vande Walle L., Festjens N., and Saelens X. Mitochondria: Breathe or Die (2005), Research Signpost, Kirala, India 77-105
8. Zong W.X., and Thompson C.B. Necrotic death as a cell fate. Genes Dev. 20 (2006) 1-15
9. Leist M., and Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev., Mol. Cell. Biol. 2 (2001) 589-598
10. Fiers W., Beyaert R., Declercq W., and Vandenabeele P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18 (1999) 7719-7730
11. Vercammen D., Brouckaert G., Denecker G., Van de Craen M., Declercq W., Fiers W., and Vandenabeele P. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188 (1998) 919-930
12. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., Bodmer J.L., Schneider P., Seed B., and Tschopp J. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1 (2000) 489-495
13. Kalai M., Van Loo G., Vanden Berghe T., Meeus A., Burm W., Saelens X., and Vandenabeele P. Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsRNA. Cell Death Differ. 9 (2002) 981-994
14. Grooten J., Goossens V., Vanhaesebroeck B., and Fiers W. Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: early events in tumour necrosis factor- induced cytotoxicity. Cytokine 5 (1993) 546-555
15. Napirei M., Wulf S., and Mannherz H.G. Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system. Arthritis Rheum. 50 (2004) 1873-1883
16. Tsukada T., Watanabe M., and Yamashima T. Implications of CAD and DNase II in ischemic neuronal necrosis specific for the primate hippocampus. J. Neurochem. 79 (2001) 1196-1206
17. Higuchi Y. Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress. Biochem. Pharmacol. 66 (2003) 1527-1535
18. Proskuryakov S.Y., Konoplyannikov A.G., and Gabai V.L. Necrosis: a specific form of programmed cell death?. Exp. Cell Res. 283 (2003) 1-16
19. Brouckaert G., Kalai M., Krysko D.V., Saelens X., Vercammen D., Ndlovu, Haegeman G., D'Herde K., and Vandenabeele P. Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol. Biol. Cell 15 (2004) 1089-1100
20. Cocco R.E., and Ucker D.S. Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure. Mol. Biol. Cell 12 (2001) 919-930
21. Vanden Berghe T., Kalai M., Denecker G., Meeus A., Saelens X., and Vandenabeele P. Necrosis is associated with IL-6 production but apoptosis is not. Cell Signal. 18 (2006) 328-335
22. Levine B., and Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 6 (2004) 463-477
23. Guimaraes C.A., Benchimol M., Amarante-Mendes G.P., and Linden R. Alternative programs of cell death in developing retinal tissue. J. Biol. Chem. 278 (2003) 41938-41946
24. Xue L., Fletcher G.C., and Tolkovsky A.M. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol. Cell. Neurosci. 14 (1999) 180-198
25. Yanagisawa H., Miyashita T., Nakano Y., and Yamamoto D. HSpin1, a transmembrane protein interacting with Bcl-2/Bcl-xL, induces a caspase-independent autophagic cell death. Cell Death Differ. 10 (2003) 798-807
26. Gozuacik D., and Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23 (2004) 2891-2906
27. Peter M.E., and Krammer P.H. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10 (2003) 26-35
28. Vercammen D., Vandenabeele P., Beyaert R., Declercq W., and Fiers W. Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells. Cytokine 9 (1997) 801-808
29. Vercammen D., Beyaert R., Denecker G., Goossens V., Van Loo G., Declercq W., Grooten J., Fiers W., and Vandenabeele P. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187 (1998) 1477-1485
30. Kawahara A., Ohsawa Y., Matsumura H., Uchiyama Y., and Nagata S. Caspase-independent cell killing by Fas-associated protein with death domain. J. Cell Biol. 143 (1998) 1353-1360
31. Lin Y., Choksi S., Shen H.M., Yang Q.F., Hur G.M., Kim Y.S., Tran J.H., Nedospasov S.A., and Liu Z.G. Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J. Biol. Chem. 279 (2004) 10822-10828
32. Vanden Berghe T., van Loo G., Saelens X., Van Gurp M., Brouckaert G., Kalai M., Declercq W., and Vandenabeele P. Differential signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD. J. Biol. Chem. 279 (2004) 7925-7933
33. Boone E., Vanden Berghe T., Van Loo G., De Wilde G., De Wael N., Vercammen D., Fiers W., Haegeman G., and Vandenabeele P. Structure/Function analysis of p55 tumor necrosis factor receptor and fas-associated death domain. Effect on necrosis in L929sA cells. J. Biol. Chem. 275 (2000) 37596-37603
34. Kischkel F.C., Lawrence D.A., Chuntharapai A., Schow P., Kim K.J., and Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12 (2000) 611-620
35. Micheau O., and Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114 (2003) 181-190
36. Schneider-Brachert W., Tchikov V., Neumeyer J., Jakob M., Winoto-Morbach S., Held-Feindt J., Heinrich M., Merkel O., Ehrenschwender M., Adam D., Mentlein R., Kabelitz D., and Schutze S. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21 (2004) 415-428
37. Harper N., Hughes M., MacFarlane M., and Cohen G.M. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. J. Biol. Chem. 278 (2003) 25534-25541
38. Devin A., Cook A., Lin Y., Rodriguez Y., Kelliher M., and Liu Z. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12 (2000) 419-429
39. Ting A.T., Pimentel-Muinos F.X., and Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J. 15 (1996) 6189-6196
40. Devin A., Lin Y., and Liu Z.G. The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep. 4 (2003) 623-627
41. Hsu H., Shu H.B., Pan M.G., and Goeddel D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84 (1996) 299-308
42. Thomas L.R., Henson A., Reed J.C., Salsbury F.R., and Thorburn A. Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD. J. Biol. Chem. 279 (2004) 32780-32785
43. Chan F.K., Shisler J., Bixby J.G., Felices M., Zheng L., Appel M., Orenstein J., Moss B., and Lenardo M.J. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J. Biol. Chem. 278 (2003) 51613-51621
44. Lin Y., Devin A., Rodriguez Y., and Liu Z.G. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13 (1999) 2514-2526
45. Hsu H., Huang J., Shu H.B., Baichwal V., and Goeddel D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4 (1996) 387-396
46. Lewis J., Devin A., Miller A., Lin Y., Rodriguez Y., Neckers L., and Liu Z.G. Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J. Biol. Chem. 275 (2000) 10519-10526
47. Vanden Berghe T., Kalai M., Van Loo G., Declercq W., and Vandenabeele P. Disruption of HSP90 function reverts tumor necrosis factor-induced necrosis to apoptosis. J. Biol. Chem. 278 (2003) 5622-5629
48. Ma Y., Temkin V., Liu H., and Pope R.M. NF-{kappa}B protects macrophages from lipopolysaccharide-induced cell death: the role of caspase-8 and receptor-interacting protein. J. Biol. Chem. 280 (2005) 41827-41834
49. Balachandran S., Roberts P.C., Kipperman T., Bhalla K.N., Compans R.W., Archer D.R., and Barber G.N. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. J. Virol. 74 (2000) 1513-1523
50. Yu L., Alva A., Su H., Dutt P., Freundt E., Welsh S., Baehrecke E.H., and Lenardo M.J. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304 (2004) 1500-1502
51. Yu L., Wan F., Dutta S., Welsh S., Liu Z., Freundt E., Baehrecke E.H., and Lenardo M. Autophagic programmed cell death by selective catalase degradation. Proc. Natl. Acad. Sci. U. S. A. (2006)
52. Xu Y., Kim S.O., Li Y., and Han J. Autophagy contributes to caspase-independent macrophage cell death. J. Biol. Chem. (2006)
53. Cosi C., Suzuki H., Milani D., Facci L., Menegazzi M., Vantini G., Kanai Y., and Skaper S.D. Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J. Neurosci. Res. 39 (1994) 38-46
54. Eliasson M.J., Sampei K., Mandir A.S., Hurn P.D., Traystman R.J., Bao J., Pieper A., Wang Z.Q., Dawson T.M., Snyder S.H., and Dawson V.L. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 3 (1997) 1089-1095
55. Burkart V., Wang Z.Q., Radons J., Heller B., Herceg Z., Stingl L., Wagner E.F., and Kolb H. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat. Med. 5 (1999) 314-319
56. Cipriani G., Rapizzi E., Vannacci A., Rizzuto R., Moroni F., and Chiarugi A. Nuclear poly(ADP-ribose) polymerase-1 rapidly triggers mitochondrial dysfunction. J. Biol. Chem. 280 (2005) 17227-17234
57. Shen H.M., Lin Y., Choksi S., Tran J., Jin T., Chang L., Karin M., Zhang J., and Liu Z.G. Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death. Mol. Cell. Biol. 24 (2004) 5914-5922
58. Alano C.C., Ying W., and Swanson R.A. Poly(ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition. J. Biol. Chem. 279 (2004) 18895-18902
59. Ha H.C., and Snyder S.H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13978-13982
60. van Wijk S.J., and Hageman G.J. Poly(ADP-ribose) polymerase-1 mediated caspase-independent cell death after ischemia/reperfusion. Free Radic. Biol. Med. 39 (2005) 81-90
61. Xu Y., Huang S., Liu Z.G., and Han J. Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J. Biol. Chem. (2006)
62. Maundrell K., Antonsson B., Magnenat E., Camps M., Muda M., Chabert C., Gillieron C., Boschert U., Vial-Knecht E., Martinou J.C., and Arkinstall S. Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J. Biol. Chem. 272 (1997) 25238-25242
63. Yamamoto K., Ichijo H., and Korsmeyer S.J. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol. Cell. Biol. 19 (1999) 8469-8478
64. Deng Y., Ren X., Yang L., Lin Y., and Wu X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 115 (2003) 61-70
65. Kang Y.H., Yi M.J., Kim M.J., Park M.T., Bae S., Kang C.M., Cho C.K., Park I.C., Park M.J., Rhee C.H., Hong S.I., Chung H.Y., Lee Y.S., and Lee S.J. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res. 64 (2004) 8960-8967
66. Morel Y., and Barouki R. Repression of gene expression by oxidative stress. Biochem. J. 3 (1999) 481-496
67. Sauer H., Wartenberg M., and Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell. Physiol. Biochem. 11 (2001) 173-186
68. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
69. Andreyev A.Y., Kushnareva Y.E., and Starkov A.A. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc.) 70 (2005) 200-214
70. Jezek P., and Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int. J. Biochem. Cell. Biol. 37 (2005) 2478-2503
71. Barja G., and Herrero A. Localization at complex I and mechanism of the higher free radical production of brain nonsynaptic mitochondria in the short-lived rat than in the longevous pigeon. J. Bioenerg. Biomembranes 30 (1998) 235-243
72. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., and Lesnefsky E.J. Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 278 (2003) 36027-36031
73. Fleury C., Mignotte B., and Vayssiere J.L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84 (2002) 131-141
74. Imai H., and Nakagawa Y. Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic. Biol. Med. 34 (2003) 145-169
75. Gutteridge J.M., and Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann. N. Y. Acad. Sci. 899 (2000) 136-147
76. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 21 (2000) 361-370
77. Engl K., and Cotter T.G. Direct oxidative modifications of signalling proteins in mammalian cells and their effects on apoptosis. Redox Rep. 10 (2005) 237-245
78. Noguchi N., Yamashita H., Hamahara J., Nakamura A., Kuhn H., and Niki E. The specificity of lipoxygenase-catalyzed lipid peroxidation and the effects of radical-scavenging antioxidants. Biol. Chem. 383 (2002) 619-626
79. Gutteridge J.M., and Mitchell J. Redox imbalance in the critically ill. Br. Med. Bull. 55 (1999) 49-75
80. Schulz J.B., Matthews R.T., Klockgether T., Dichgans J., and Beal M.F. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol. Cell. Biochem. 174 (1997) 193-197
81. Halestrap A.P., Kerr P.M., Javadov S., and Woodfield K.Y. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim. Biophys. Acta 1366 (1998) 79-94
82. Heirman I., and Grooten J. Eicosanoid mediators in health, inflammation and cancer. Recent Res. Dev. Cell Biol. 1 (2003) 177-201
83. Matthews N., Neale M.L., Jackson S.K., and Stark J.M. Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Immunology 62 (1987) 153-155
84. Schulze-Osthoff K., Bakker A.C., Vanhaesebroeck B., Beyaert R., Jacob W.A., and Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267 (1992) 5317-5323
85. Goossens V., De Vos K., Vercammen D., Steemans M., Vancompernolle K., Fiers W., Vandenabeele P., and Grooten J. Redox regulation of TNF signaling. BioFactors 10 (1999) 145-156
86. Festjens N., Kalai M., Smet J., Meeus A., Van Coster R., Saelens X., and Vandenabeele P. Butylated hydroxyanisole is more than a reactive oxygen species scavenger. Cell Death Differ. 13 (2006) 166-169
87. Cauwels A., Janssen B., Waeytens A., Cuvelier C., and Brouckaert P. Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat. Immunol. 4 (2003) 387-393
88. Matthews N. Anti-tumour cytotoxin produced by human monocytes: studies on its mode of action. Br. J. Cancer 48 (1983) 405-410
89. Van Herreweghe F., Mao J., Chaplen F.W., Grooten J., Gevaert K., Vandekerckhove J., and Vancompernolle K. Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 949-954
90. Thornalley P.J. The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem. J. 269 (1990) 1-11
91. Lo T.W., Westwood M.E., McLellan A.C., Selwood T., and Thornalley P.J. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin. J. Biol. Chem. 269 (1994) 32299-32305
92. Westwood M.E., and Thornalley P.J. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins. J. Protein. Chem. 14 (1995) 359-372
93. Oya T., Hattori N., Mizuno Y., Miyata S., Maeda S., Osawa T., and Uchida K. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J. Biol. Chem. 274 (1999) 18492-18502
94. Corman B., Duriez M., Poitevin P., Heudes D., Bruneval P., Tedgui A., and Levy B.I. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 1301-1306
95. Hennet T., Bertoni G., Richter C., and Peterhans E. Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res. 53 (1993) 1456-1460
96. Denecker G., Vercammen D., Steemans M., Vanden Berghe T., Brouckaert G., Van Loo G., Zhivotovsky B., Fiers W., Grooten J., Declercq W., and Vandenabeele P. Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria. Cell Death Differ. 8 (2001) 829-840
97. Ray R., Chen G., Vande Velde C., Cizeau J., Park J.H., Reed J.C., Gietz R.D., and Greenberg A.H. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J. Biol. Chem. 275 (2000) 1439-1448
98. Vande Velde C., Cizeau J., Dubik D., Alimonti J., Brown T., Israels S., Hakem R., and Greenberg A. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol. Cell. Biol. 20 (2000) 5454-5468
99. Paik S.G., and Lee H. Regulation of BNIP3 in normal and cancer cells. Mol. Cells 21 (2006) 1-6
100. Shimizu S., Eguchi Y., Kamiike W., Funahashi Y., Mignon A., Lacronique V., Matsuda H., and Tsujimoto Y. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 1455-1459
101. Shimizu S., Eguchi Y., Kosaka H., Kamiike W., Matsuda H., and Tsujimoto Y. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374 (1995) 811-813
102. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., and Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75 (1993) 241-251
103. Esposti M.D., Hatzinisiriou I., McLennan H., and Ralph S. Bcl-2 and mitochondrial oxygen radicals. New approaches with reactive oxygen species-sensitive probes. J. Biol. Chem. 274 (1999) 29831-29837
104. Balaban R.S. Cardiac energy metabolism homeostasis: role of cytosolic calcium. J. Mol. Cell. Cardiol. 34 (2002) 1259-1271
105. Hansford R.G., and Zorov D. Role of mitochondrial calcium transport in the control of substrate oxidation. Mol. Cell. Biochem. 184 (1998) 359-369
106. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., and Sheu S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 287 (2004) C817-C833
107. Formigli L., Papucci L., Tani A., Schiavone N., Tempestini A., Orlandini G.E., Capaccioli S., and Orlandini S.Z. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J. Cell. Physiol. 182 (2000) 41-49
108. Kim J.S., He L., and Lemasters J.J. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun. 304 (2003) 463-470
109. Weiss J.N., Korge P., Honda H.M., and Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ. Res. 93 (2003) 292-301
110. Lemasters J.J., Nieminen A.L., Qian T., Trost L.C., Elmore S.P., Nishimura Y., Crowe R.A., Cascio W.E., Bradham C.A., Brenner D.A., and Herman B. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366 (1998) 177-196
111. Cross H.R., Opie L.H., Radda G.K., and Clarke K. Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. Circ. Res. 78 (1996) 482-491
112. Brucklacher R.M., Vannucci R.C., and Vannucci S.J. Hypoxic preconditioning increases brain glycogen and delays energy depletion from hypoxia-ischemia in the immature rat. Dev. Neurosci. 24 (2002) 411-417
113. Xiong Z.G., Zhu X.M., Chu X.P., Minami M., Hey J., Wei W.L., MacDonald J.F., Wemmie J.A., Price M.P., Welsh M.J., and Simon R.P. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 118 (2004) 687-698
114. Griffiths E.J., and Halestrap A.P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem. J. 307 Pt. 1 (1995) 93-98
115. Buttgereit F., and Brand M.D. A hierarchy of ATP-consuming processes in mammalian cells. Biochem. J. 312 Pt. 1 (1995) 163-167
116. Waring P. Redox active calcium ion channels and cell death. Arch. Biochem. Biophys. 434 (2005) 33-42
117. Kokoszka J.E., Waymire K.G., Levy S.E., Sligh J.E., Cai J., Jones D.P., MacGregor G.R., and Wallace D.C. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427 (2004) 461-465
118. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., Brunskill E.W., Sayen M.R., Gottlieb R.A., Dorn G.W., Robbins J., and Molkentin J.D. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434 (2005) 658-662
119. Nakagawa T., Shimizu S., Watanabe T., Yamaguchi O., Otsu K., Yamagata H., Inohara H., Kubo T., and Tsujimoto Y. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434 (2005) 652-658
120. Basso E., Fante L., Fowlkes J., Petronilli V., Forte M.A., and Bernardi P. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J. Biol. Chem. 280 (2005) 18558-18561
121. Schinzel A.C., Takeuchi O., Huang Z., Fisher J.K., Zhou Z., Rubens J., Hetz C., Danial N.N., Moskowitz M.A., and Korsmeyer S.J. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12005-12010
122. Schulze-Osthoff K., Krammer P.H., and Droge W. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13 (1994) 4587-4596
123. Saelens X., Festjens N., Parthoens E., Vanoverberghe I., Kalai M., van Kuppeveld F., and Vandenabeele P. Protein synthesis persists during necrotic cell death. J. Cell Biol. 168 (2005) 545-551
124. Xu K., Tavernarakis N., and Driscoll M. Necrotic cell death in C. elegans requires the function of calreticulin and regulators of Ca(2+) release from the endoplasmic reticulum. Neuron 31 (2001) 957-971
125. Bredt D.S., and Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 682-685
126. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357 (2001) 593-615
127. Shiva S., and Darley-Usmar V.M. Control of the nitric oxide-cytochrome c oxidase signaling pathway under pathological and physiological conditions. IUBMB Life 55 (2003) 585-590
128. Jekabsone A., Ivanoviene L., Brown G.C., and Borutaite V. Nitric oxide and calcium together inactivate mitochondrial complex I and induce cytochrome c release. J. Mol. Cell. Cardiol. 35 (2003) 803-809
129. Mannick J.B., Hausladen A., Liu L., Hess D.T., Zeng M., Miao Q.X., Kane L.S., Gow A.J., and Stamler J.S. Fas-induced caspase denitrosylation. Science 284 (1999) 651-654
130. Sattler R., and Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24 (2001) 107-129
131. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., and Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 6368-6371
132. Pieper A.A., Verma A., Zhang J., and Snyder S.H. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol. Sci. 20 (1999) 171-181
133. Murakami M., and Kudo I. Phospholipase A2. J. Biochem. (Tokyo) 131 (2002) 285-292
134. Evans J.H., Spencer D.M., Zweifach A., and Leslie C.C. Intracellular calcium signals regulating cytosolic phospholipase A2 translocation to internal membranes. J. Biol. Chem. 276 (2001) 30150-30160
135. Diez E., Louis-Flamberg P., Hall R.H., and Mayer R.J. Substrate specificities and properties of human phospholipases A2 in a mixed vesicle model. J. Biol. Chem. 267 (1992) 18342-18348
136. Brash A.R. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 274 (1999) 23679-23682
137. Jones G.D., Russell L., Darley-Usmar V.M., Stone D., and Wilson M.T. Role of lipid hydroperoxides in the activation of 15-lipoxygenase. Biochemistry 35 (1996) 7197-7203
138. Spiteller G. Are lipid peroxidation processes induced by changes in the cell wall structure and how are these processes connected with diseases?. Med. Hypotheses 60 (2003) 69-83
139. Kuhn H., Belkner J., Wiesner R., and Brash A.R. Oxygenation of biological membranes by the pure reticulocyte lipoxygenase. J. Biol. Chem. 265 (1990) 18351-18361
140. van Leyen K., Duvoisin R.M., Engelhardt H., and Wiedmann M. A function for lipoxygenase in programmed organelle degradation. Nature 395 (1998) 392-395
141. Maccarrone M., Melino G., and Finazzi-Agro A. Lipoxygenases and their involvement in programmed cell death. Cell Death Differ. 8 (2001) 776-784
142. Suffys P., Beyaert R., De Valck D., Vanhaesebroeck B., Van Roy F., and Fiers W. Tumour-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se. Eur. J. Biochem. 195 (1991) 465-475
143. Hayakawa M., Ishida N., Takeuchi K., Shibamoto S., Hori T., Oku N., Ito F., and Tsujimoto M. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biol. Chem. 268 (1993) 11290-11295
144. El Mahdani N.E., Ameyar M., Cai Z., Colard O., Masliah J., and Chouaib S. Resistance to TNF-induced cytotoxicity correlates with an abnormal cleavage of cytosolic phospholipase A2. J. Immunol. 165 (2000) 6756-6761
145. Kohjimoto Y., Kennington L., Scheid C.R., and Honeyman T.W. Role of phospholipase A2 in the cytotoxic effects of oxalate in cultured renal epithelial cells. Kidney Int. 56 (1999) 1432-1441
146. Sapirstein A., Spech R.A., Witzgall R., and Bonventre J.V. Cytosolic phospholipase A2 (PLA2), but not secretory PLA2, potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells. J. Biol. Chem. 271 (1996) 21505-21513
147. Shinzawa K., and Tsujimoto Y. PLA2 activity is required for nuclear shrinkage in caspase-independent cell death. J. Cell Biol. 163 (2003) 1219-1230
148. Sorimachi Y., Harada K., Saido T.C., Ono T., Kawashima S., and Yoshida K. Downregulation of calpastatin in rat heart after brief ischemia and reperfusion. J. Biochem. (Tokyo) 122 (1997) 743-748
149. Wang K.K. Calpain and caspase: can you tell the difference?. Trends Neurosci. 23 (2000) 20-26
150. Liu X., Van Vleet T., and Schnellmann R.G. The role of calpain in oncotic cell death. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 349-370
151. Bano D., Young K.W., Guerin C.J., Lefeuvre R., Rothwell N.J., Naldini L., Rizzuto R., Carafoli E., and Nicotera P. Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell 120 (2005) 275-285
152. Syntichaki P., Xu K., Driscoll M., and Tavernarakis N. Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature 419 (2002) 939-944
153. Spencer M.J., Croall D.E., and Tidball J.G. Calpains are activated in necrotic fibers from mdx dystrophic mice. J. Biol. Chem. 270 (1995) 10909-10914
154. Yamashima T., Saido T.C., Takita M., Miyazawa A., Yamano J., Miyakawa A., Nishijyo H., Yamashita J., Kawashima S., Ono T., and Yoshioka T. Transient brain ischaemia provokes Ca2+, PIP2 and calpain responses prior to delayed neuronal death in monkeys. Eur. J. Neurosci. 8 (1996) 1932-1944
155. Yamashima T., Tonchev A.B., Tsukada T., Saido T.C., Imajoh-Ohmi S., Momoi T., and Kominami E. Sustained calpain activation associated with lysosomal rupture executes necrosis of the postischemic CA1 neurons in primates. Hippocampus 13 (2003) 791-800
156. Yamashima T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog. Neurobiol. 62 (2000) 273-295
157. Yamashima T., Kohda Y., Tsuchiya K., Ueno T., Yamashita J., Yoshioka T., and Kominami E. Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. Eur. J. Neurosci. 10 (1998) 1723-1733
158. Nakayama M., Ishidoh K., Kayagaki N., Kojima Y., Yamaguchi N., Nakano H., Kominami E., Okumura K., and Yagita H. Multiple pathways of TWEAK-induced cell death. J. Immunol. 168 (2002) 734-743
159. Mouatt-Prigent A., Karlsson J.O., Agid Y., and Hirsch E.C. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?. Neuroscience 73 (1996) 979-987
160. Karlsson J.O., Blennow K., Janson I., Blomgren K., Karlsson I., Regland B., Wallin A., and Gottfries C.G. Increased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease. Neurobiol. Aging 16 (1995) 901-906
161. Nilsson E., Alafuzoff I., Blennow K., Blomgren K., Hall C.M., Janson I., Karlsson I., Wallin A., Gottfries C.G., and Karlsson J.O. Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue. Neurobiol. Aging 11 (1990) 425-431
162. Kalra J., Lautner D., Massey K.L., and Prasad K. Oxygen free radicals induced release of lysosomal enzymes in vitro. Mol. Cell. Biochem. 84 (1988) 233-238
163. Ollinger K., and Brunk U.T. Cellular injury induced by oxidative stress is mediated through lysosomal damage. Free Radic. Biol. Med. 19 (1995) 565-574
164. Yu Z., Persson H.L., Eaton J.W., and Brunk U.T. Intralysosomal iron: a major determinant of oxidant-induced cell death. Free Radic. Biol. Med. 34 (2003) 1243-1252
165. Li W., Yuan X., Nordgren G., Dalen H., Dubowchik G.M., Firestone R.A., and Brunk U.T. Induction of cell death by the lysosomotropic detergent MSDH. FEBS Lett. 470 (2000) 35-39
166. Boya P., Andreau K., Poncet D., Zamzami N., Perfettini J.L., Metivier D., Ojcius D.M., Jaattela M., and Kroemer G. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J. Exp. Med. 197 (2003) 1323-1334
167. Zhao M., Antunes F., Eaton J.W., and Brunk U.T. Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. Eur. J. Biochem. 270 (2003) 3778-3786
168. Robertson A.S., Belorgey D., Lilley K.S., Lomas D.A., Gubb D., and Dafforn T.R. Characterization of the necrotic protein that regulates the Toll-mediated immune response in Drosophila. J. Biol. Chem. 278 (2003) 6175-6180
169. Green C., Levashina E., McKimmie C., Dafforn T., Reichhart J.M., and Gubb D. The necrotic gene in Drosophila corresponds to one of a cluster of three serpin transcripts mapping at 43A1.2. Genetics 156 (2000) 1117-1127
170. Suffys P., Beyaert R., Van Roy F., and Fiers W. Involvement of a serine protease in tumour-necrosis-factor-mediated cytotoxicity. Eur. J. Biochem. 178 (1988) 257-265
171. Strelow A., Bernardo K., Adam-Klages S., Linke T., Sandhoff K., Kronke M., and Adam D. Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. J. Exp. Med. 192 (2000) 601-612
172. Jayadev S., Hayter H.L., Andrieu N., Gamard C.J., Liu B., Balu R., Hayakawa M., Ito F., and Hannun Y.A. Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells. J. Biol. Chem. 272 (1997) 17196-17203
173. Thon L., Mohlig H., Mathieu S., Lange A., Bulanova E., Winoto-Morbach S., Schutze S., Bulfone-Paus S., and Adam D. Ceramide mediates caspase-independent programmed cell death. FASEB J. 19 (2005) 1945-1956
174. Ramos B., Lahti J.M., Claro E., and Jackowski S. Prevalence of necrosis in C2-ceramide-induced cytotoxicity in NB16 neuroblastoma cells. Mol. Pharmacol. 64 (2003) 502-511
175. Zhao S., Yang Y.N., and Song J.G. Ceramide induces caspase-dependent and -independent apoptosis in A-431 cells. J. Cell. Physiol. 199 (2004) 47-56
176. Luschen S., Ussat S., Scherer G., Kabelitz D., and Adam-Klages S. Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression. J. Biol. Chem. 275 (2000) 24670-24678
177. Matsumura H., Shimizu Y., Ohsawa Y., Kawahara A., Uchiyama Y., and Nagata S. Necrotic death pathway in Fas receptor signaling. J. Cell Biol. 151 (2000) 1247-1256
178. De Vos K., Goossens V., Boone E., Vercammen D., Vancompernolle K., Vandenabeele P., Haegeman G., Fiers W., and Grooten J. The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region. J. Biol. Chem. 273 (1998) 9673-9680
179. Vancompernolle K., Boonefaes T., Mann M., Fiers W., and Grooten J. Tumor necrosis factor-induced microtubule stabilization mediated by hyperphosphorylated oncoprotein 18 promotes cell death. J. Biol. Chem. 275 (2000) 33876-33882
180. Li J., Li Q., Xie C., Zhou H., Wang Y., Zhang N., Shao H., Chan S.C., Peng X., Lin S.C., and Han J. Beta-actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell death. J. Cell Sci. 117 (2004) 4673-4680
181. Fadok V.A., Bratton D.L., and Henson P.M. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J. Clin. Invest. 108 (2001) 957-962
182. Krysko D.V., Denecker G., Festjens N., Gabriels S., Parthoens E., D'Herde K., and Vandenabeele P. Macrophages use different internalization mechanisms to clear apoptotic and necrotic cells. Cell Death Differ. (2006)
183. Krysko O., De Ridder L., and Cornelissen M. Phosphatidylserine exposure during early primary necrosis (oncosis) in JB6 cells as evidenced by immunogold labeling technique. Apoptosis 9 (2004) 495-500
184. Waring P., Lambert D., Sjaarda A., Hurne A., and Beaver J. Increased cell surface exposure of phosphatidylserine on propidium iodide negative thymocytes undergoing death by necrosis. Cell Death Differ. 6 (1999) 624-637
185. Arur S., Uche U.E., Rezaul K., Fong M., Scranton V., Cowan A.E., Mohler W., and Han D.K. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev. Cell 4 (2003) 587-598
186. Devitt A., Pierce S., Oldreive C., Shingler W.H., and Gregory C.D. CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine. Cell Death Differ. 10 (2003) 371-382
187. Mitchell J.E., Cvetanovic M., Tibrewal N., Patel V., Colamonici O.R., Li M.O., Flavell R.A., Levine J.S., Birge R.B., and Ucker D.S. The presumptive phosphatidylserine receptor is dispensable for innate anti-inflammatory recognition and clearance of apoptotic cells. J. Biol. Chem. 281 (2006) 5718-5725
188. Cvetanovic M., and Ucker D.S. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J. Immunol. 172 (2004) 880-889
189. Casiano C.A., Ochs R.L., and Tan E.M. Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ. 5 (1998) 183-190
190. Utz P.J., and Anderson P. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum. 41 (1998) 1152-1160
191. van Venrooij W.J., and Pruijn G.J. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res. 2 (2000) 249-251
192. Casciola-Rosen L., Andrade F., Ulanet D., Wong W.B., and Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J. Exp. Med. 190 (1999) 815-826
193. Nicholas B., Smethurst P., Verderio E., Jones R., and Griffin M. Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity. Biochem. J. 371 (2003) 413-422
194. Barker R.N., Erwig L., Pearce W.P., Devine A., and Rees A.J. Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages. Pathobiology 67 (1999) 302-305
195. Basu S., Binder R.J., Suto R., Anderson K.M., and Srivastava P.K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12 (2000) 1539-1546
196. Sauter B., Albert M.L., Francisco L., Larsson M., Somersan S., and Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 91 (2000) 423-434
197. Scaffidi P., Misteli T., and Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 (2002) 91-95
198. Bonaldi T., Langst G., Strohner R., Becker P.B., and Bianchi M.E. The DNA chaperone HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding. EMBO J. 21 (2002) 6865-6873
199. Muller S., Scaffidi P., Degryse B., Bonaldi T., Ronfani L., Agresti A., Beltrame M., and Bianchi M.E. New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J. 20 (2001) 4337-4340
200. Park J.S., Svetkauskaite D., He Q., Kim J.Y., Strassheim D., Ishizaka A., and Abraham E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279 (2004) 7370-7377
201. Lotze M.T., and Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev., Immunol. 5 (2005) 331-342
202. Erlandsson Harris H., and Andersson U. Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator. Eur. J. Immunol. 34 (2004) 1503-1512
203. Melcher A., Gough M., Todryk S., and Vile R. Apoptosis or necrosis for tumor immunotherapy: what's in a name?. J. Mol. Med. 77 (1999) 824-833
204. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev., Immunol. 2 (2002) 185-194
205. Todryk S.M., Melcher A.A., Dalgleish A.G., and Vile R.G. Heat shock proteins refine the danger theory. Immunology 99 (2000) 334-337
206. Kariko K., Ni H., Capodici J., Lamphier M., and Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 279 (2004) 12542-12550
207. Saelens X., Kalai M., and Vandenabeele P. Translation inhibition in apoptosis: caspase-dependent PKR activation and eIF2-alpha phosphorylation. J. Biol. Chem. 276 (2001) 41620-41628
208. Clemens M.J., Bushell M., Jeffrey I.W., Pain V.M., and Morley S.J. Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ. 7 (2000) 603-615
209. Wada T., and Penninger J.M. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23 (2004) 2838-2849
210. Roulston A., Reinhard C., Amiri P., and Williams L.T. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J. Biol. Chem. 273 (1998) 10232-10239
211. Nagata Y., and Todokoro K. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 94 (1999) 853-863
212. Sakon S., Xue X., Takekawa M., Sasazuki T., Okazaki T., Kojima Y., Piao J.H., Yagita H., Okumura K., Doi T., and Nakano H. NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 22 (2003) 3898-3909
213. Kamata H., Honda S., Maeda S., Chang L., Hirata H., and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661
214. Walker N.I., Harmon B.V., Gobe G.C., and Kerr J.F. Patterns of cell death. Methods Achiev. Exp. Pathol. 13 (1988) 18-54
215. Murdoch W.J., Wilken C., and Young D.A. Sequence of apoptosis and inflammatory necrosis within the formative ovulatory site of sheep follicles. J. Reprod. Fertil. 117 (1999) 325-329
216. Blom W.M., De Bont H.J., Meijerman I., Kuppen P.J., Mulder G.J., and Nagelkerke J.F. Interleukin-2-activated natural killer cells can induce both apoptosis and necrosis in rat hepatocytes. Hepatology 29 (1999) 785-792
217. Jaattela M., and Tschopp J. Caspase-independent cell death in T lymphocytes. Nat. Immunol. 4 (2003) 416-423
218. Roach H.I., and Clarke N.M. Physiological cell death of chondrocytes in vivo is not confined to apoptosis. New observations on the mammalian growth plate. J. Bone Jt. Surg., Br. 82 (2000) 601-613
219. Barkla D.H., and Gibson P.R. The fate of epithelial cells in the human large intestine. Pathology 31 (1999) 230-238
220. Chautan M., Chazal G., Cecconi F., Gruss P., and Golstein P. Interdigital cell death can occur through a necrotic and caspase-independent pathway. Curr. Biol. 9 (1999) 967-970
221. Borthwick N.J., Wickremasinghe R.G., Lewin J., Fairbanks L.D., and Bofill M. Activation-associated necrosis in human immunodeficiency virus infection. J. Infect Dis. 179 (1999) 352-360
222. Lenardo M.J., Angleman S.B., Bounkeua V., Dimas J., Duvall M.G., Graubard M.B., Hornung F., Selkirk M.C., Speirs C.K., Trageser C., Orenstein J.O., and Bolton D.L. Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env. J. Virol. 76 (2002) 5082-5093
223. Plymale D.R., Tang D.S., Comardelle A.M., Fermin C.D., Lewis D.E., and Garry R.F. Both necrosis and apoptosis contribute to HIV-1-induced killing of CD4 cells. Aids 13 (1999) 1827-1839
224. Brennan M.A., and Cookson B.T. Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol. Microbiol. 38 (2000) 31-40
225. Francois M., Le Cabec V., Dupont M.A., Sansonetti P.J., and Maridonneau-Parini I. Induction of necrosis in human neutrophils by Shigella flexneri requires type III secretion, IpaB and IpaC invasins, and actin polymerization. Infect. Immun. 68 (2000) 1289-1296
226. Schwabe R.F., and Brenner D.A. Mechanisms of Liver Injury. I. TNF-{alpha}-induced liver injury: role of IKK, JNK, and ROS pathways. Am. J. Physiol.: Gastrointest. Liver Physiol. 290 (2006) G583-G589
227. Fujikawa D.G. Confusion between neuronal apoptosis and activation of programmed cell death mechanisms in acute necrotic insults. Trends Neurosci. 23 (2000) 410-411
228. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 21 (2000) 383-421
229. Kaplowitz N. Mechanisms of liver cell injury. J. Hepatol. 32 (2000) 39-47
230. Zhang S.Q., Kovalenko A., Cantarella G., and Wallach D. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. Immunity 12 (2000) 301-311
231. Kelliher M.A., Grimm S., Ishida Y., Kuo F., Stanger B.Z., and Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8 (1998) 297-303
232. Lamkanfi M., D'Hondt K., Vande Walle L., van Gurp M., Denecker G., Demeulemeester J., Kalai M., Declercq W., Saelens X., and Vandenabeele P. A novel caspase-2 complex containing TRAF2 and RIP1. J. Biol. Chem. 280 (2005) 6923-6932
233. Osford S.M., Dallman C.L., Johnson P.W., Ganesan A., and Packham G. Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cells. Curr. Med. Chem. 11 (2004) 1031-1039
234. Fesik S.W. Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev., Cancer 5 (2005) 876-885
235. Zong W.X., Ditsworth D., Bauer D.E., Wang Z.Q., and Thompson C.B. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev. 18 (2004) 1272-1282
236. Agostinis P., Buytaert E., Breyssens H., and Hendrickx N. Regulatory pathways in photodynamic therapy induced apoptosis. Photochem. Photobiol. Sci. 3 (2004) 721-729
237. Almeida R.D., Manadas B.J., Carvalho A.P., and Duarte C.B. Intracellular signaling mechanisms in photodynamic therapy. Biochim. Biophys. Acta 1704 (2004) 59-86
238. Wiegmann K., Schutze S., Machleidt T., Witte D., and Kronke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78 (1994) 1005-1015
239. Hurwitz R., Ferlinz K., and Sandhoff K. The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. Biol. Chem. Hoppe-Seyler. 375 (1994) 447-450